| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/15/2004 | US20040138195 Activation using enzyme or ionizing radiation |
| 07/15/2004 | US20040138194 Hormone replacement therapy |
| 07/15/2004 | US20040138193 Administering by mouth |
| 07/15/2004 | US20040138192 Crystalline forms of halobetasol propionate |
| 07/15/2004 | US20040138191 Crystallization in methylene chloride, diethyl ether mixtures; topical antiinflammatory drug |
| 07/15/2004 | US20040138190 Steroidal quinols and their use for estrogen replacement therapy |
| 07/15/2004 | US20040138189 Moderation of intracellular signals; antitumor agents; drug screening; administering cucurbitacin compound |
| 07/15/2004 | US20040138188 Prevent pathology variations of signal transduction of steroid, hormone receptors |
| 07/15/2004 | US20040138187 Therapeutic treatment methods |
| 07/15/2004 | US20040138186 3-Nitrogen-6, 7-dioxygen steroids and uses related thereto |
| 07/15/2004 | US20040138183 Bactericides; anticarcinogenic agents; modulation of gene expression; therapy for antibiotic resistant bacteria |
| 07/15/2004 | US20040138181 Phytanic acid derivative compositions and method of treating and/or preventing diabetes mellitus |
| 07/15/2004 | US20040138180 Bisphosphonate composition and process for the preparation thereof |
| 07/15/2004 | US20040138179 Antifungal formulations |
| 07/15/2004 | US20040138178 Modulate amyloid deposits |
| 07/15/2004 | US20040138177 Therapeutic composition for broad spectrum dermal disease |
| 07/15/2004 | US20040138175 Peptide boronic acid drug; thrombosis therapy; anticoagulants |
| 07/15/2004 | US20040138174 Use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for treating cervical erosion |
| 07/15/2004 | US20040138173 Chlamydia oligosaccharides |
| 07/15/2004 | US20040138172 Drug product for intestinal disease |
| 07/15/2004 | US20040138171 Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors |
| 07/15/2004 | US20040138170 Viricides; administering nucleoside with anoth compound such as interferons, interleukin or drug |
| 07/15/2004 | US20040138169 Competitive binding with enzyme involved in metabolism of homoocysteine; permeability of erythrocyte membrane; enzyme inhibitor |
| 07/15/2004 | US20040138160 Administering tyrosine kinase inhibitor; suppression signal; blocking her gene |
| 07/15/2004 | US20040138153 enzyme inhibitors; drug screening |
| 07/15/2004 | US20040138152 adriamycin; chemotherapy; sustained release |
| 07/15/2004 | US20040138151 solvent extraction; plant extracts; chromatography |
| 07/15/2004 | US20040138150 Motilide compounds |
| 07/15/2004 | US20040138149 slurrying; precipitation; for treatment of bacterial infections |
| 07/15/2004 | US20040138147 Compounds and methods for treating transplant rejection |
| 07/15/2004 | US20040138146 Methods for preventing or treating cardiac arrhythmia |
| 07/15/2004 | US20040138145 Application of intestinal biliary acid reuptake inhibitors for the prevention and treatment of alzheimer's disease |
| 07/15/2004 | US20040138143 Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 07/15/2004 | US20040138142 Carbohydrate derivatives of paclitaxel and docetaxel, method for producing same and uses thereof |
| 07/15/2004 | US20040138140 Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy |
| 07/15/2004 | US20040138125 Composition and method to prevent and treat brain and spinal cord injuries |
| 07/15/2004 | US20040138124 immunostimulants used for prophylaxis or prevention diseases related to enzymatic deficiency, to stimulate in vivo hydrolysis of xenobiotics, drugs and toxins, or as antiallergens; metabolic and genetic disorders |
| 07/15/2004 | US20040138121 administering to mammals antitumor agents comprising mixtures of endothelin agonists, anticarcinogenic agents and optionally angiogenesis inhibitors |
| 07/15/2004 | US20040138109 Viricides such as ciluprevir in solutions of polyethylene glycol, ethanol, propylene glycol, water and/or mixtures, used for prophylaxis or prevention of hepatitis C virus (HCV) infections |
| 07/15/2004 | US20040138102 Use of a substantially cell membrane impermeable compound for treating arthritis |
| 07/15/2004 | US20040138095 Colloidal suspension of nanoparticles based on an amphiphilic copolymer |
| 07/15/2004 | US20040138094 Disease caused by peroxisome proliferator activator receptors ; administering moderator; anticholesterol agents |
| 07/15/2004 | US20040138074 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 07/15/2004 | US20040137620 Compositions corresponding to a calcium transporter and methods of making and using same |
| 07/15/2004 | US20040137554 Diagnosis and treatment of bacterial infections |
| 07/15/2004 | US20040137531 Methods of screening for inhibitors of phospholipid synthesis related to glycolipid-storage diseases |
| 07/15/2004 | US20040137530 for diagnostic assays/genetically engineering drugs and vaccines |
| 07/15/2004 | US20040137526 first, second and third seperation of multiple polypeptides in a sample depends on charging, hydrophobicity and size accordingly |
| 07/15/2004 | US20040137492 Novel polypeptide |
| 07/15/2004 | US20040137485 consisting of a substantially uncharged antisense oligomer with ratio of uncharged linkages to charged linkages in the oligomer is at least 4:1, preferably at least 5:1, and more preferably at least 8:1 |
| 07/15/2004 | US20040137446 Fab I and inhibition of apicomplexan parasites |
| 07/15/2004 | US20040137156 for sustained release; compressed tablets/capsules |
| 07/15/2004 | US20040137127 Exhibiting improved solubility (e.g., light transmittance), taste, color, and texture characteristics, for use in foods and beverages |
| 07/15/2004 | US20040137096 An antiinflammatory agent of a hops extract including a active alpha acid and 0.5-10 wt % beta acid; treating osteoarthritis, rheumatoid arthritis and chronic pain with reduced gastric side effects; potent and selective enzyme inhibitors |
| 07/15/2004 | US20040137092 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 07/15/2004 | US20040137090 Mixture of methylhydroxychalcone polymer (MHCP) and chromium; antidiabetic agents |
| 07/15/2004 | US20040137088 Improved, color-stable extract of St John's wort having reduced or absent amounts of chorophyll and proanthocyanidins; gels for skin disorders and mucous membrane irritations; acne, atopic dermatitis; neurodermatitis; bactericides; viricides |
| 07/15/2004 | US20040137082 Administrating an extract of Cystoseira canariensis, i.e., seaweed and derivatives, comprising one or more polysaccharide sulfates, preferably having nine or less units; health; muscular disorders |
| 07/15/2004 | US20040137081 Attaining sexual wellness and health of the sexual vascular system with proanthocyanidins |
| 07/15/2004 | US20040137080 Multivitamin regimen for renal patients |
| 07/15/2004 | US20040137079 A stable aqueous solution of hyaluronic acid, a stabilized oxy-chloro complex, e.g., chlorine dioxide, a boric acid/borate buffer to maintain a pH of 6-9 and no more than 0.0075% hydrogen peroxide; storage; conditioning; increased comfort; dry eye |
| 07/15/2004 | US20040137078 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 07/15/2004 | US20040137071 Nanocapsule encapsulation system and method |
| 07/15/2004 | US20040137070 Drug particles from freezing onto a surface |
| 07/15/2004 | US20040137069 Pirenzepine ophthalmic gel |
| 07/15/2004 | US20040137068 A sterile formulation of a biocompatible chelating agent, a permeability promoter, Advanced Glycation Endproducts (AGE) selected from breakers, formation inhibitors, and glycation inhibitors and a carrier; vision defects; inserts |
| 07/15/2004 | US20040137066 treating vascular disease by diagnosing the pathology and then coating the implant with the appropriate therapeutic agent to treat it; coating contaings a mixture of rapamycin and another therapeutic agent |
| 07/15/2004 | US20040137064 Compositions and processes using siRNA, amphipathic compounds and polycations |
| 07/15/2004 | US20040137060 monodispersed microspheres; made by transforming to liquiform in the absence of dissolving medium, to liquiflash conditions, said liquid having substantially unimpeded internal flow, and imparting shear force to form particles, coating particles |
| 07/15/2004 | US20040137058 Effervescent bisphosphonate formulation |
| 07/15/2004 | US20040137056 prepared without the addition of binder; instead, the drug itself acts as a binder; dosage forms; fosamax for example |
| 07/15/2004 | US20040137055 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 07/15/2004 | US20040137052 mixture of a drug having anti-allergy, anti-histamine, anti-inflammatory, anti-PAF (platelet-aggregating factor) or eosinophile chemotaxis inhibiting activity and an acid; dosage form; excellent in the digestive tract absorbability and stability |
| 07/15/2004 | US20040137051 Wound healing compositions and methods of use |
| 07/15/2004 | US20040137049 Amphotericin b aqueous composition |
| 07/15/2004 | US20040137045 Hot-melt TTS for administering Rotigotine |
| 07/15/2004 | US20040137037 gel comprising a protein that does not coagulate at pH 3 to 4; calcium; acid; carbohydrate; fat; emulsifier; agar; and water; food; nutraceutical; increasing blood (plasma) volume for improved excercise endurance, heat tolerance |
| 07/15/2004 | US20040137034 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 07/15/2004 | US20040137023 5-Cholesten-3beta, 25-diol-7-one, esters and ethers thereof, particularly for the treatment of dry skin and scalp |
| 07/15/2004 | US20040137012 beta (1 --> 3) glucan derived from vegetable material(shiitake mushroom) by hydrolysis or alcohol precipitation, and having a molecular weight of from about 5,000 to about 20,000. |
| 07/15/2004 | US20040137010 gp120 and a nucleic acid aptamer that binds to gp120 and induces gp120 to undergo a conformational shift whereby an epitope to a membrane bound receptor is exposed that is capable of eliciting a humoral immune response |
| 07/15/2004 | US20040137005 Chlamydia protein, sequence and uses thereof |
| 07/15/2004 | US20040136992 modulating inflammatory and immunoregulatory responses associated with cardiovascular disease with soluble receptor, fusion proteins, and/or antibodies of IL-17, IL-18 antagonist, 4-1BB, CD30 and OX40 |
| 07/15/2004 | US20040136970 negatively charged carrier, such as hyaluronic acid, are administered to a synovial joint, the stimulatory effects of the FGF18 are enhanced |
| 07/15/2004 | US20040136953 diagnosing aggressive form of respiratory condition by a different T helper cell response when samples are incubated with antigen characteristic of condition; treatment with interferon gamma |
| 07/15/2004 | US20040136948 Branched immunomodulatory compounds and methods of using the same |
| 07/15/2004 | US20040136938 with a fucose component; cosmetic; pharaceutical; topical application; with the proviso that the vitamin component is not ascorbyl palmitate nor Vitamin A palmitate |
| 07/15/2004 | US20040136925 mixture of hyaluronic acids of various molecular weight, properly added with suitable diluents, which demonstrated to possess an interesting antiflogistic, antioxidant and tissue repair activity |
| 07/15/2004 | US20040136922 film delivers at least one oral care agent, such as antimicrobial agents and salivary stimulants |
| 07/15/2004 | US20040136920 aerosol formulation which comprises particulate salbutamol or a physiologically acceptable salt or solvate thereof and 1,1,1,2-tetrafluoroethane as propellant, which formulation is substantially free of surfactant |
| 07/15/2004 | US20040136919 Tiotropium containing powder formulation for inhalation |
| 07/15/2004 | US20040136918 salmeterol xinafoate and fluticasone propionate in a metered does inhaler with propellant |
| 07/15/2004 | US20040136917 disposing an amount of the imidazoquinolinamine formulation into a first nare of a virally infected individual to reduce the duration of symptoms associated with the common cold or viral rhinitis |
| 07/15/2004 | US20040136915 Buccal, polar and non-polar spray containing atropine |
| 07/15/2004 | US20040136914 Buccal, polar and non-polar spray containing ondansetron |
| 07/15/2004 | US20040136913 Buccal, polar and non-polar spray containing sumatriptan |
| 07/15/2004 | US20040136904 Dry powder compositions comprising labelled particles for inhalation |
| 07/15/2004 | US20040135130 Nonlinear optical compounds and methods for their preparation |
| 07/15/2004 | US20040135119 Liquid crystalline polymers mixture:, display, optics, diagnosis |
| 07/15/2004 | US20040134387 obtained from plant by-products or waste suspended through wet-grinding and suspended by means of a microballs mill; includes silica fume, fly ashes, heavy ashes, slags or stone sludge, in form of pellets, sludge or blocks |